Sex: F
Vaccine: COVID19
Symptoms: Biopsy, Lichen planus, Oral disorder, Vulval disorder
Clinical narrative: Had vulvar issues and lesions; Had vulvar issues and lesions; Was diagnosed by biopsy as lichen planus; Diagnosed by biopsy as lichen planus, which had flare up after booster; Had oral lesions; This is a spontaneous report received from contactable reporter(s) (Physician). The reporter is the patient.  A 50-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), in Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 50 , in left arm for covid-19 immunisation. The patient's relevant medical history included: "Seasonal allergies" (unspecified if ongoing), notes: Known allergies: Seasonal allergies. Concomitant medication(s) included: ALBUTEROL [SALBUTAMOL]. Vaccination history included: BNT162b2 (Dose Number: 2, Batch/Lot No: Unknown. Unable to locate or read the details, Location of injection: Arm Left), administration date: 14Jan2021, when the patient was 50-year-old, for COVID-19 immunization, reaction(s): "Had vulvar issues and lesions", "Was diagnosed by biopsy as lichen planus"; Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Unable to locate or read the details, Location of injection: Arm Left), administration date: Dec2020, when the patient was 50 years old, for COVID-19 immunization. The following information was reported: LICHEN PLANUS (non-serious) with onset 2021, outcome "not recovered", described as "Diagnosed by biopsy as lichen planus, which had flare up after booster"; ORAL DISORDER (non-serious) with onset 2021, outcome "not recovered", described as "Had oral lesions"; VULVAL DISORDER (non-serious), VULVAL DISORDER (non-serious) all with onset 2021, outcome "not recovered" and all described as "Had vulvar issues and lesions"; LICHEN PLANUS (non-serious) with onset 2021, outcome "not recovered", described as "Was diagnosed by biopsy as lichen planus". The events "had vulvar issues and lesions", "was diagnosed by biopsy as lichen planus", "diagnosed by biopsy as lichen planus, which had flare up after booster" and "had oral lesions" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of vulval disorder, vulval disorder, lichen planus, lichen planus, oral disorder.  Additional information: The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient received Multivitamins and Albuterol inhaler prn within 2 weeks of vaccination. It was reported that, the patient had vulvar issues and lesions which was diagnosed by biopsy as lichen planus, which had flare up after booster. After booster, she had oral lesions also for which she visited her dentist and was still getting workup for lichen planus. She was due for the second booster, but worried about flare up. The patient was treated with steroids topical, tacrolimus topical and dental visit was done. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination, she had not been tested for COVID-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.